Sym.04 Targeting Tumor & Tumor Microenvironment for Cancer Therapy
September 30 (Mon), 09:30-11:30, Rm. 401
Ju Gyeong Kang (National Heart, Lung, and Blood Institute, NIH, USA)
Tae Woo Kim (Korea University, Korea)
MOON-CHANG BAEK (Kyungpook National University, Korea)
Seok-Hyung Kim (Sungkyunkwan University, Korea)
Yu-Kyeong Hwang (Cell Therapy Research Center, GC LabCell, Korea)
Heuijoon Park (Fred Hutchinson Cancer Research Center, USA)
This session compose: (I) immunoediting in cancer cells & tumor microenvironment(TME), (ii) exosomes secreted by cancer cells, (III) response from neighbor stromal cells (fibroblasts), (IV) understanding of the NK cell therapy and (V) Jens project. The tumor microenvironment is a heterogeneous tissue that in addition to tumor cells, contain tumor-associated cell types such as immune cells, fibroblasts, and endothelial cells. Tumor growth creates hypoxia, oxidative stress and acidosis within the TME triggering an adjustment of the extracellular matrix (ECM), a response from neighbor stromal cells (e.g., fibroblasts) and immune cells (lymphocytes and macrophages), inducing angiogenesis and, ultimately, resulting in metastasis. Exosomes secreted by tumor or TME cells are central players in all these events. Some new therapeutic options that include drugs targeting microenvironment components are achieving encouraging results in reducing the number of tumors and/or overcoming their resistance in preclinical studies. And also, increased understanding of the NK cell response to TME has provided a better understanding of their impaired function in tumors which may aid in the development of novel immunotherapeutic strategies to enhance NK cell responses in cancer patients.
Coordinators & Chairs: Sang-Kyu Ye (Seoul National University, Korea)
Yong-Nyun Kim (National Cancer Center, Korea)